Showing results (851-860 of 889) with videos related to

Sort By:
Pageof 89
American Journal of Clinical Oncology|July 12, 2016
ACR Appropriateness Criteria® Management of Recurrent Endometrial CancerMohamed A Elshaikh, Sean Vance, David K Gaffney, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 23, 2021
Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patientsPatrick O Hanafin, Roger L Nation, Marc H Scheetz, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
The Journal of Biological Chemistry|March 20, 2014
Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastomaYu Qin, Maoyong Fu, Masamichi Takahashi, et al.
Nature Medicine|February 15, 2022
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trialA Stewart Campbell, Brittany D Needham, Christopher R Meyer, et al.
Molecular Pharmaceutics|August 17, 2023
Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid FormulationsShekhar B Yeshwante, Patrick Hanafin, Brittany K Miller, et al.
Journal of Global Antimicrobial Resistance|July 16, 2025
Emerging resistance to novel β-lactam β-lactamase inhibitor combinations in Klebsiella pneumoniae bearing KPC variantsMase Hamza, German M Traglia, Lucia Maccari, et al.
International Journal of Molecular Sciences|November 9, 2024
Insights into <i>Acinetobacter baumannii</i> AMA205's Unprecedented Antibiotic ResistanceGerman Matias Traglia, Fernando Pasteran, Samyar Moheb, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2025
Emerging Resistance to Novel -βLactam β-Lactamase Inhibitor Combinations in Klebsiella pneumoniae bearing KPC VariantsMase Hamza, German M M Traglia, Lucia Maccari, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2025
Restoring cefepime activity against multidrug-resistant KPC-producing <i>Klebsiella pneumoniae</i> by combination with boronic acid inhibitors, MB076 and S02030Laura J Rojas, Travis B Nielsen, Paul Pantapalangkoor, et al.
Pageof 89